While numerous studies have established that aberrant expression of PD-L1 in cancer promoted cancer immune escape and blockade of the PD-L1-enhanced anti-tumour response [4, 5], the prognostic role of PD-L1 in HCC has remained inconsistent. This evidence concerns the gene CD274 and hepatocellular carcinoma.